Comparative Study of Sulfiredoxin-1 with Selected Inflammatory Markers in Chronic Kidney Disease Patients Pre- and Post-Hemodialysis
Israa University Journal for Applied Science · 01.04.2026 · 9 (1) · 1-16
DOI: 10.52865/iaqm8648 ↗Kurz gefasst
Fachartikel in der Zeitschrift Israa University Journal for Applied Science, online erschienen am 01.04.2026. Verfasst von Rana I. Atiyah und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Chronic kidney disease (CKD) is a progressive disorder defined by a persistent reduction in glomerular filtration rate below 60 mL/min/1.73 m² for at least three months. Oxidative stress(OS) play key roles in CKD progression and may be aggravated by repeated hemodialysis sessions. Sulfiredoxin-1 (Srx-1) is a recently identified antioxidant protein involved in reversing oxidative damage and regulating redox signaling; however, its clinical relevance in CKD remains unclear.
Methods
A total of 140 participants were enrolled, including 100 CKD patients on hemodialysis and 40 healthy controls. Serum levels of Srx-1, kidney injury molecule-1 (KIM-1), and interleukin-18 (IL-18) were measured using enzyme-linked immunosorbent assay. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) were determined using standard BIOLABO (France) biochemical kits.
Results
Compared with healthy controls, CKD patients showed significantly elevated levels of Srx-1, IL-18, KIM-1, and ALP, along with significantly reduced ALT and AST levels. ALT levels increased significantly after hemodialysis compared with pre-dialysis values. Patients receiving twelve dialysis sessions per month exhibited higher Srx-1, IL-18, and KIM-1 levels than those undergoing eight sessions monthly, while ALP levels were lower. No significant differences were observed regarding age, disease duration, or underlying causes between the groups.
Conclusion
The findings demonstrate a close relationship between OS inflammation, and dialysis frequency in CKD. Elevated Srx-1 levels with increased dialysis frequency may represent a compensatory antioxidant response to cumulative OS. Nevertheless, Srx-1 may not be a reliable standalone biomarker, emphasizing the need for further large-scale studies to clarify its clinical significance.
Zitieren
APA
Atiyah, R. I., Al-Helaly, L. A., & AL-abady, F. M. (2026). Comparative Study of Sulfiredoxin-1 with Selected Inflammatory Markers in Chronic Kidney Disease Patients Pre- and Post-Hemodialysis. Israa University Journal for Applied Science, 9(1), 1-16. https://doi.org/10.52865/iaqm8648
Vancouver
Atiyah RI, Al-Helaly LA, AL-abady FM. Comparative Study of Sulfiredoxin-1 with Selected Inflammatory Markers in Chronic Kidney Disease Patients Pre- and Post-Hemodialysis. Israa University Journal for Applied Science. 2026;9(1):1-16. doi:10.52865/iaqm8648
BibTeX
@article{Atiyah2026,
author = {Atiyah, Rana I. and Al-Helaly, Luay A. and AL-abady, Faiz M.},
title = {Comparative Study of Sulfiredoxin-1 with Selected Inflammatory Markers in Chronic Kidney Disease Patients Pre- and Post-Hemodialysis},
journal = {Israa University Journal for Applied Science},
year = {2026},
volume = {9},
number = {1},
pages = {1--16},
doi = {10.52865/iaqm8648}
}
EUVIMED